+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Shingles Vaccine Market by Vaccine Type, Age Group, End User, Distribution Channel, Dosage - Global Forecast to 2030- Product Image
Shingles Vaccine Market by Vaccine Type, Age Group, End User, Distribution Channel, Dosage - Global Forecast to 2030- Product Image
Sale

Shingles Vaccine Market by Vaccine Type, Age Group, End User, Distribution Channel, Dosage - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5716361
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

As global public health priorities evolve, the shingles vaccine market is gaining greater focus among industry leaders. Decision-makers are seeking actionable insights to manage risk, optimize market access, and effectively navigate emerging opportunities within this vital immunization landscape.

Market Snapshot: Shingles Vaccine Market Overview

The shingles vaccine market grew from USD 1.87 billion in 2024 to USD 2.02 billion in 2025. It is expected to maintain robust momentum, expanding at a CAGR of 8.16% and reaching USD 2.99 billion by 2030. Growth is underpinned by aging populations, evolving vaccine technologies, and intensifying policy support for adult immunization across developed and emerging markets. Senior executives will recognize the growing importance of strategic investments and agile adaptation within this dynamic sector.

Scope & Segmentation

This report delivers in-depth analysis across core market dimensions. Key segmentations include:

  • Vaccine Types: Recombinant zoster vaccine; zoster vaccine live.
  • Age Groups: 50 to 59 years, 60 to 69 years, 70 years and above.
  • End Users: Clinics (community and private); hospitals (general and specialty).
  • Distribution Channels: Hospital pharmacies, online pharmacies (including digital and e-commerce platforms), and retail pharmacies (chain and independent).
  • Dosage Formats: Multi dose, single dose.
  • Geographic Regions: Americas (including the United States by state, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Companies: GlaxoSmithKline plc, Merck & Co., Inc., SK chemicals, GeneOne Life Science, CanSinoBIO.

Segmentation enables stakeholders to target growth corridors, understand channel preferences, and tailor investment strategies to evolving market realities.

Key Takeaways for Senior Decision-Makers

  • Adult immunization for shingles is accelerating due to demographic shifts, with government and payer support raising coverage expectations across all markets.
  • Technology advancements in formulation, cold chain optimization, and digital health are reducing operational complexities and enhancing patient engagement.
  • Partnerships between pharmaceutical manufacturers, contract suppliers, and distribution networks are crucial to ensure supply continuity and rapid response to market disruptions.
  • Patients are driving demand for tailored vaccination experiences, increasing interest in flexible scheduling and multi-format delivery channels.
  • Regional nuances—from established infrastructures in the Americas to rapid growth in Asia-Pacific—require adaptive go-to-market approaches and close collaboration with local stakeholders.
  • Competitive differentiation is being shaped by investment in recombinant vaccine platforms, next-generation candidates, and real-world evidence to demonstrate added value.

Tariff Impact on the Shingles Vaccine Market

The 2025 US tariff regime on imported pharmaceutical components is influencing input costs throughout the shingles vaccine supply chain. Manufacturers are pursuing local sourcing strategies and investing in domestic production as a hedge against future policy uncertainties. Distributors are refining inventory models to balance new costs with service levels, while transparent communication along the supply chain supports sustained access and market trust. Over time, tariff dynamics may accelerate development of cost-efficient manufacturing and alternative sourcing channels for vaccine components.

Methodology & Data Sources

This report integrates primary research, including interviews with healthcare experts and supply chain leaders, with secondary research from peer-reviewed sources, regulatory filings, and industry data. Data consistency is ensured through multinational triangulation and ongoing validation, providing a strong foundation for strategic planning. Sensitivity analyses and scenario modeling further enhance insight reliability across potential future conditions.

Why This Report Matters

  • Enables C-suite executives to identify strategic market opportunities, optimize investment, and preempt disruption from regulatory and policy shifts.
  • Delivers actionable guidance on prioritizing technologies, partnerships, and geographic expansion to drive growth and operational efficiency.
  • Provides tailored segmentation and risk insights supporting informed decision-making and competitive advantage in the evolving shingles vaccine landscape.

Conclusion

The shingles vaccine market offers significant prospects for organizations able to adapt to demographic, technological, and policy shifts. Data-driven strategies grounded in robust research and regional realities will best position decision-makers for sustained success and market resilience.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Shingles Vaccine Market, by Vaccine Type
8.1. Introduction
8.2. Recombinant Zoster Vaccine
8.3. Zoster Vaccine Live
9. Shingles Vaccine Market, by Age Group
9.1. Introduction
9.2. 50 To 59 Years
9.3. 60 To 69 Years
9.4. 70 Years And Above
10. Shingles Vaccine Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. Community Clinics
10.2.2. Private Clinics
10.3. Hospitals
10.3.1. General Hospitals
10.3.2. Specialty Hospitals
11. Shingles Vaccine Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.3.1. Digital Pharmacies
11.3.2. E-commerce Platforms
11.4. Retail Pharmacies
11.4.1. Chain Pharmacies
11.4.2. Independent Pharmacies
12. Shingles Vaccine Market, by Dosage
12.1. Introduction
12.2. Multi Dose
12.3. Single Dose
13. Americas Shingles Vaccine Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Shingles Vaccine Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Shingles Vaccine Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. GlaxoSmithKline plc
16.3.2. Merck & Co., Inc.
16.3.3. SK chemicals
16.3.4. GeneOne Life Science
16.3.5. CanSinoBIO
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SHINGLES VACCINE MARKET MULTI-CURRENCY
FIGURE 2. SHINGLES VACCINE MARKET MULTI-LANGUAGE
FIGURE 3. SHINGLES VACCINE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SHINGLES VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SHINGLES VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SHINGLES VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SHINGLES VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. SHINGLES VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. SHINGLES VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SHINGLES VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SHINGLES VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SHINGLES VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SHINGLES VACCINE MARKET SIZE, BY RECOMBINANT ZOSTER VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SHINGLES VACCINE MARKET SIZE, BY ZOSTER VACCINE LIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SHINGLES VACCINE MARKET SIZE, BY 50 TO 59 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SHINGLES VACCINE MARKET SIZE, BY 60 TO 69 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SHINGLES VACCINE MARKET SIZE, BY 70 YEARS AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SHINGLES VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SHINGLES VACCINE MARKET SIZE, BY COMMUNITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SHINGLES VACCINE MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SHINGLES VACCINE MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SHINGLES VACCINE MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SHINGLES VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DIGITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SHINGLES VACCINE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SHINGLES VACCINE MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SHINGLES VACCINE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SHINGLES VACCINE MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SHINGLES VACCINE MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. CANADA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 56. CANADA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 57. CANADA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. CANADA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 59. CANADA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 60. CANADA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. CANADA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 62. CANADA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 63. CANADA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 65. MEXICO SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 66. MEXICO SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. MEXICO SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 68. MEXICO SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. MEXICO SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 71. MEXICO SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 72. MEXICO SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 110. GERMANY SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 111. GERMANY SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 112. GERMANY SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. GERMANY SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 114. GERMANY SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 115. GERMANY SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. GERMANY SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 117. GERMANY SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 118. GERMANY SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 120. FRANCE SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 121. FRANCE SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. FRANCE SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 123. FRANCE SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 124. FRANCE SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. FRANCE SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 126. FRANCE SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 127. FRANCE SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 137. ITALY SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 138. ITALY SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 139. ITALY SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. ITALY SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 141. ITALY SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 142. ITALY SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. ITALY SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 144. ITALY SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 145. ITALY SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 146. SPAIN SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 147. SPAIN SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 148. SPAIN SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. SPAIN SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 150. SPAIN SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 151. SPAIN SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. SPAIN SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 153. SPAIN SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 154. SPAIN SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 174. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 178. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 182. DENMARK SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 183. DENMARK SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 184. DENMARK SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. DENMARK SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 186. DENMARK SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 187. DENMARK SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. DENMARK SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 189. DENMARK SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 190. DENMARK SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 191. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 192. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 193. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 200. QATAR SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 201. QATAR SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 202. QATAR SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. QATAR SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 204. QATAR SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 205. QATAR SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. QATAR SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 207. QATAR SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 208. QATAR SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 209. FINLAND SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 210. FINLAND SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 211. FINLAND SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. FINLAND SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 213. FINLAND SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 214. FINLAND SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. FINLAND SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 216. FINLAND SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 217. FINLAND SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 219. SWEDEN SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 220. SWEDEN SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 222. SWEDEN SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 223. SWEDEN SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. SWEDEN SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 227. NIGERIA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 228. NIGERIA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 229. NIGERIA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. NIGERIA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 231. NIGERIA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 236. EGYPT SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 237. EGYPT SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 238. EGYPT SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. EGYPT SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 240. EGYPT SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 241. EGYPT SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. EGYPT SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 243. EGYPT SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 244. EGYPT SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 245. TURKEY SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 246. TURKEY SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 247. TURKEY SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. TURKEY SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 249. TURKEY SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 250. TURKEY SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. TURKEY SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 252. TURKEY SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 253. TURKEY SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 254. ISRAEL SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 255. ISRAEL SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 256. ISRAEL SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. ISRAEL SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 258. ISRAEL SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 259. ISRAEL SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 263. NORWAY SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 264. NORWAY SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 265. NORWAY SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. NORWAY SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 267. NORWAY SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 268. NORWAY SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. NORWAY SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 270. NORWAY SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 271. NORWAY SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 272. POLAND SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 273. POLAND SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 274. POLAND SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. POLAND SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 276. POLAND SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 277. POLAND SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. POLAND SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 279. POLAND SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 280. POLAND SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 281. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 282. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 283. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 285. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 286. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 287. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 288. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 290. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 291. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 292. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 294. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 295. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 296. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 300. CHINA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 301. CHINA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 302. CHINA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. CHINA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 304. CHINA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 305. CHINA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. CHINA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 307. CHINA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 308. CHINA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 309. INDIA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 310. INDIA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 311. INDIA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. INDIA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 313. INDIA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 314. INDIA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 315. INDIA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 316. INDIA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 317. INDIA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 318. JAPAN SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 319. JAPAN SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 320. JAPAN SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. JAPAN SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 322. JAPAN SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 323. JAPAN SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 324. JAPAN SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 325. JAPAN SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 326. JAPAN SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 327. AUSTRALIA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 328. AUSTRALIA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 329. AUSTRALIA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 330. AUSTRALIA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 331. AUSTRALIA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 332. AUSTRALIA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 333. AUSTRALIA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 334. AUSTRALIA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 335. AUSTRALIA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 336. SOUTH KOREA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 337. SOUTH KOREA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 338. SOUTH KOREA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 339. SOUTH KOREA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 340. SOUTH KOREA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 341. SOUTH KOREA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 342. SOUTH KOREA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 343. SOUTH KOREA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 344. SOUTH KOREA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 345. INDONESIA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 346. INDONESIA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 347. INDONESIA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 348. INDONESIA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 349. INDONESIA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 350. INDONESIA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 351. INDONESIA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 352. INDONESIA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 353. INDONESIA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 354. THAILAND SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 355. THAILAND SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 356. THAILAND SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 357. THAILAND SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 358. THAILAND SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 359. THAILAND SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Shingles Vaccine market report include:
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • SK chemicals
  • GeneOne Life Science
  • CanSinoBIO

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.02 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.99 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned6

Related Topics

Related Reports

Shingles Vaccines - Global Strategic Business Report - Product Image

Shingles Vaccines - Global Strategic Business Report

  • Report
  • 269 Pages
  • Global
From
Shingles Vaccine Market Size, Share & Trends Analysis Report By Product (Shingrix, Zostavax), By Type (Recombinant Vaccine), By End-use (Private Healthcare Settings), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Shingles Vaccine Market Size, Share & Trends Analysis Report By Product (Shingrix, Zostavax), By Type (Recombinant Vaccine), By End-use (Private Healthcare Settings), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 90 Pages
  • Global
From
Adult Vaccine Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Adult Vaccine Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Adult Vaccines - Global Strategic Business Report - Product Image

Adult Vaccines - Global Strategic Business Report

  • Report
  • 377 Pages
  • Global
From
Adult Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Adult Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Shingles Vaccine Market

The Shingles Vaccine is a vaccine used to prevent shingles, a painful skin condition caused by the varicella-zoster virus. It is recommended for adults over the age of 50, and is available in both single-dose and two-dose formulations. The vaccine is typically administered by a healthcare provider, and is available in both private and public healthcare settings. The Shingles Vaccine market is a subset of the larger Vaccines market, which is estimated to be worth billions of dollars. The Shingles Vaccine market is expected to grow in the coming years, driven by an aging population and increased awareness of the condition. Some of the major companies in the Shingles Vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and AstraZeneca. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.